HUBUNGAN PENUNDAAN JADWAL PENGOBATAN KEMOTERAPI DENGAN TINGKAT KECEMASAN PASIEN KANKER PAYUDARA (CA MAMMAE) DI MURNI TEGUH MEMORIAL HOSPITAL

Authors

  • Rutnita Pentasary Manurung
  • Hizkianta Sembiring

DOI:

https://doi.org/10.37104/j7d99982

Keywords:

Chemotherapy delay, anxiety, breast cancer, Ca mammae, HADS

Abstract

Breast cancer is a global health issue with a steadily rising incidence. Chemotherapy, as a primary treatment, requires precise scheduling; however, delays frequently occur and can cause psychological distress, specifically anxiety, in patients. This study aimed to determine the relationship between chemotherapy schedule delays and anxiety levels in breast cancer patients. Methods: A quantitative, correlational, analytical study with a cross-sectional design was conducted. A sample of 55 patients was selected using purposive sampling. Data collection instruments included a chemotherapy delay observation sheet and the HADS-A questionnaire. Data were analyzed using the Spearman Rho test. Results: The majority of respondents were aged 41–60 years (61.3%), had a high school education (58.1%), were unemployed (72.7%), were at stage III of the disease (47.3%), and had undergone a moderate number of chemotherapy cycles (49.1%). Regarding chemotherapy scheduling, the largest group experienced no delays (56.4%), while the dominant anxiety level was mild (54.5%). A significant, strong relationship was found between chemotherapy schedule delays and patient anxiety levels (p-value = 0.000; r = 0.622). The greater the delay in the chemotherapy schedule experienced by the patient, the higher the level of anxiety felt. Future researchers are advised to include variables such as family support and economic status, and to employ qualitative approaches or intervention studies.

Downloads

Published

2026-11-18